Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-15

Clinical Trial Update: Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hypofractionated radiation therapy to reduce recurrence in patients with breast cancer after surgery; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 | Phase 3 | Status: COMPLETED | Results posted: 2023-06-15